Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 1/20 | 0.58 |
| ▸ | ABL1 | P00519 | 1/20 | 0.58 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.58 |
| ▸ | LCK | P06239 | 1/20 | 0.58 |
| ▸ | CSF1R | P07333 | 1/20 | 0.58 |
| ▸ | RET | P07949 | 1/20 | 0.58 |
| ▸ | MET | P08581 | 1/20 | 0.58 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.58 |
| ▸ | PIM1 | P11309 | 1/20 | 0.58 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.58 |
| ▸ | FLT3 | P36888 | 1/20 | 0.58 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.58 |
| ▸ | CDK8 | P49336 | 1/20 | 0.58 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.58 |
| ▸ | MAP4K2 | Q12851 | 1/20 | 0.58 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.58 |
| ▸ | NTRK3 | Q16288 | 1/20 | 0.58 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.58 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28873007 | 0.88 | AURKA (0.59) | AURKAABL1NTRK1LCKCSF1R | |
| SCHEMBL2997318 | 0.88 | CCR1 (0.60) | AURKAABL1NTRK1LCKCSF1R | |
| SCHEMBL2477927 | 0.82 | CCR1 (0.71) | AURKAABL1NTRK1LCKCSF1R | |
| SCHEMBL10000248 | 0.80 | CCR1 (0.68) | AURKAABL1NTRK1LCKCSF1R | |
| SCHEMBL10000250 | 0.80 | CCR1 (0.54) | AURKAABL1NTRK1LCKCSF1R | |
| SCHEMBL13750539 | 0.80 | TDO2 (0.46) | AURKAABL1NTRK1LCKCSF1R | |
| SCHEMBL17051514 | 0.80 | CCR1 (0.75) | AURKAABL1NTRK1LCKCSF1R | |
| SCHEMBL23253055 | 0.79 | NPC1 (0.49) | AURKAABL1NTRK1LCKCSF1R | |
| SCHEMBL12987394 | 0.79 | NPC1 (0.53) | METNPC1KDM1ARXFP1BRS3 | |
| SCHEMBL2840143 | 0.79 | NPC1 (0.49) | AURKAABL1NTRK1LCKCSF1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10403833-B2 | Organic metal complexes | MERCK PATENT GMBH (DE) | 2019-09-03 | — | — | US | disclosed |
| EP-2856528-B1 | METAL COMPLEXES COMPRISING CONDENSED HETEROAROMATIC RINGS | MERCK PATENT GMBH (DE) | 2019-07-03 | — | — | EP | disclosed |
| EP-2483263-B1 | HETEROCYCLIC COMPOUNDS THAT ARE ERK INHIBITORS | MERCK SHARP & DOHME (US) | 2018-07-18 | — | — | EP | disclosed |
| US-9879177-B2 | Metal complexes comprising condensed heteroaromatic rings | MERCK PATENT GMBH (DE) | 2018-01-30 | — | — | US | disclosed |
| US-9879177-B2 | Metal complexes comprising condensed heteroaromatic rings | MERCK PATENT GMBH (DE) | 2018-01-30 | — | — | US | disclosed |
| US-20170317298-A1 | ORGANIC METAL COMPLEXES | UDC IRELAND LIMITED (IE) | 2017-11-02 | — | — | US | disclosed |
| US-20170317298-A1 | ORGANIC METAL COMPLEXES | UDC IRELAND LIMITED (IE) | 2017-11-02 | — | — | US | disclosed |
| US-9748502-B2 | Organic metal complexes | MERCK PATENT GMBH (DE) | 2017-08-29 | — | — | US | disclosed |
| US-9748502-B2 | Organic metal complexes | MERCK PATENT GMBH (DE) | 2017-08-29 | — | — | US | disclosed |
| EP-2791275-B1 | ORGANIC SENSITIZERS FOR UP-CONVERSION | MERCK PATENT GMBH (DE) | 2017-05-31 | — | — | EP | disclosed |
| US-20140350642-A1 | Metal Complexes Comprising 1,2,3-Triazoles | MERCK PATENT GMBH (DE) | 2014-11-27 | — | — | US | disclosed |
| US-20140350642-A1 | Metal Complexes Comprising 1,2,3-Triazoles | MERCK PATENT GMBH (DE) | 2014-11-27 | — | — | US | disclosed |
| US-8658651-B2 | Compounds that are ERK inhibitors | MERCK SHARP & DOHME CORP. (US) | 2014-02-25 | — | — | US | disclosed |
| WO-2013174471-A1 | METAL COMPLEXES COMPRISING CONDENSED HETEROAROMATIC RINGS | MERCK PATENT GMBH (DE) | 2013-11-28 | — | — | WO | disclosed |
| US-8546404-B2 | Compounds that are ERK inhibitors | MERCK SHARP & DOHME (US) | 2013-10-01 | — | — | US | disclosed |
| WO-2013107487-A1 | ORGANIC METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2013-07-25 | — | — | WO | disclosed |
| WO-2013097920-A1 | METAL COMPLEXES COMPRISING 1,2,3-TRIAZOLES | MERCK PATENT GMBH (DE) | 2013-07-04 | — | — | WO | disclosed |
| WO-2013087162-A1 | ORGANIC SENSITIZERS FOR UP-CONVERSION | MERCK PATENT GMBH (DE) | 2013-06-20 | — | — | WO | disclosed |
| US-20090118284-A1 | Novel compounds that are ERK inhibitors | MERCK SHARP & DOHME LLC | 2009-05-07 | — | — | US | disclosed |
| US-20070191604-A1 | Novel compounds that are ERK inhibitors | SCHERING CORPORATION | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090118284-A1 | Novel compounds that are ERK inhibitors | MAPK1, MAPK4, MAPK10 | AURKA 780/4885ABL1 76/4885NTRK1 2365/4885 |
| US-10403833-B2 | Organic metal complexes | SOD1, ORC3, PPIA | AURKA 1560/4885ABL1 1985/4885NTRK1 4318/4885 |
| US-20070191604-A1 | Novel compounds that are ERK inhibitors | MAPK1, MAPK4, MAPKAPK2 | AURKA 589/4885ABL1 76/4885NTRK1 2700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.